Results 101 to 110 of about 4,196 (141)

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery. [PDF]

Radiol Oncol
Jurca T, Boltezar L, Orazem M, Komlos KF, Pohar K, Jevnikar S, Poljak M, Mastnak DM, Kozjek NR, Vratanar B, Ocvirk J, Ihan A.   +11 more
europepmc   +1 more source

The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes. [PDF]

Hum Vaccin Immunother
Heusler AA, Weintraub A, Stein D, Melamed-Yekel Y, Kalfon S, Pasternak Y, Kulak D.   +6 more
europepmc   +1 more source

Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study. [PDF]

Med Sci Monit
Demirel Ç, Kibar F, Dağlıoğlu G, Çetiner S, Candevir A, İnal AS, Yücel Karakaya SP, Görüroğlu Öztürk Ö, Gümüş HH, İnal TC.   +9 more
europepmc   +1 more source

Commentary on "Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery". [PDF]

Acta Derm Venereol
Daungsupawong H, Wiwanitkit V.
europepmc   +1 more source

Robust neutralization of emerging JN.1 subvariants by the updated JN.1 vaccine: rationale for catch-up booster recommendations in high-risk individuals. [PDF]

Front Immunol
Choi JY, Kim SH, Park S, Jang HM, Lee YJ, Kim HJ, Kim D, Ko JH, Jeong HS.   +8 more
europepmc   +1 more source

Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumors. [PDF]

Sci Rep
Cernera G, De Placido P, Pietroluongo E, Tortora M, Palmieri G, Giuliano M, Castaldo G, Gelzo M.   +7 more
europepmc   +1 more source

Seven-month persistence of COVID-19 vaccine-induced lymphadenopathy: a case report. [PDF]

J Med Case Rep
Hwang MK, Dua H, Mulligan AM, Escallon J.   +3 more
europepmc   +1 more source

Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study. [PDF]

Hum Vaccin Immunother
Smolinski M, Chew JL, Constantinescu C, Buchan CA, Burton C, Carignan A, Castellucci LA, Suresh S, McConnell A, Morris SK, Naus M, Pernica JM, Pham-Huy A, Piche-Renaud PP, Sadarangani M, Top KA, Cowan J, Special Immunization Clinic Network investigators.   +17 more
europepmc   +1 more source

Safety of BNT162b2 mRNA COVID-19 Vaccine Batches: A Nationwide Cohort Study. [PDF]

Pharmacoepidemiol Drug Saf
Hviid A, Svalgaard IB.
europepmc   +1 more source